Herrera-Añazco P, Sánchez-Pérez L, Córdova-Cueva L

Language: Spanish
References: 23
Page: 42-47
PDF size: 194.46 Kb.

ABSTRACT

Objective: To determine the prevalence, clinical characteristics, and evolution of the patients and healthcare staff with COVID-19 infection in a national reference hemodialysis center. Methodology. Observational and retrospective study in a cohort of patients on chronic hemodialysis and healthcare staff with COVID-19 infection at the Dos de Mayo National Hospital in Lima from March 1 to June 12, 2020. Results. Were evaluated 48 patients and 52 healthcare staff. Were positive for COVID-19 33.3% of patients and 7.6% of healthcare staff. Were symptomatic 56.2% of the patients and 18.7% required hospitalization. No one on the staff had symptoms. To date, none of the patients evaluated has required mechanical ventilation or has died. Conclusions. COVID-19 infection among patients is high. Two out of ten patients have required hospitalization, without any deceased.

REFERENCES

1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet.2020;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5.

2. Acosta G, Escobar G, Bernaola G, Alfaro J, TaypeW, Marcos C, et al. Caracterización de pacientescon COVID-19 grave atendidos en un hospital dereferencia nacional del Perú. Rev Peru Med ExpSalud Pública. 2020;37(2):253-8. doi: 10.17843/rpmesp.2020.372.5437.

3. World Health Organization. Novel Coronavirus (2019-nCoV), Situation Report 1, 21 january 2020 [Internet].WHO: 2020, [5 p.]. Disponible en: (consulta:20/05/2020).

4. Wang X, Fang X, Cai Z, Wu X, Gao X, Min J, et al.Comorbid chronic diseases and acute organ injuriesare strongly correlated with disease severity andmortality among COVID-19 patients: a systemicreview and meta-analysis. Research (Wash DC).2020;2020:2402961. doi: 10.34133/2020/2402961.

5. Henry BM, Lippi G. Chronic kidney disease is associatedwith severe coronavirus disease 2019 (COVID-19)infection. Int Urol Nephrol. 2020;52(6):1193-4. doi:10.1007/s11255-020-02451-9.

6. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, DongL, et al. Kidney disease is associated with in-hospitaldeath of patients with COVID-19. Kidney Int.2020;97(5):829-838. doi: 10.1016/j.kint.2020.03.005.

7. Ikizler TA, Kliger AS. Minimizing the risk ofCOVID-19 among patients on dialysis. Nat Rev Nephrol.2020;16(6):311-3. doi: 10.1038/s41581-020-0280-y.

8. Ma Y, Diao B, Lv X, Zhu J, Liang W, Liu L, et al.2019 novel coronavirus disease in hemodialysis (HD)patients: report from one HD center in Wuhan,China. medRxiv preprint [published: feb. 27, 2020].doi: 10.1101/2020.02.24.20027201.

9. Manganaro M, Baldovino S; Working Group of thePiedmont and Aosta Valley Section of the SIN. Firstconsiderations on the SARS-CoV-2 epidemic in theDialysis Units of Piedmont and Aosta Valley, NorthernItaly. J Nephrol. 2020;33(3):393-5. doi: 10.1007/s40620-020-00732-1.

10. Perú. Ministerio de Salud. Sala Situacional COVID-19[Internet]. Disponible en: (consulta: 13/06/2020).

11. ¿Por qué Perú es el segundo país de América Latinacon más casos de COVID-19? [Internet]. Semana, 23mayo 2020. Disponible en: (consulta: 13/06/2020).

12. Herrera-Añazco P, Atamari-Anahui N, Flores-BenítesV. Número de nefrólogos, servicios de hemodiálisisy tendencia de la prevalencia de enfermedad renalcrónica en el Ministerio de Salud de Perú. Rev PeruMed Exp Salud Pública. 2019;36(1):62‐7. doi: 10.17843/rpmesp.2019.361.4253.

13. Herrera-Añazco P, Benítes-Zapata VA, HernándezAV. Factores asociados a mortalidad intrahospitalariade una población en hemodiálisis en el Perú. RevPeru Med Exp Salud Pública. 2015;32(3):479‐84. doi:10.17843/rpmesp.2015.323.1677.

14. Soto A. Barreras para una atención eficaz en loshospitales de referencia del Ministerio de Saluddel Perú: atendiendo pacientes en el siglo XXIcon recursos del siglo XX. Rev Peru Med ExpSalud Pública. 2019;36(2):304-11. doi: 10.17843/rpmesp.2019.362.4425.

15. Basile C, Combe C, Pizzarelli F, Covic A, Davenport A,Kanbay M, et al. Recommendations for the prevention,mitigation and containment of the emerging SARSCoV-2 (COVID-19) pandemic in haemodialysiscentres. Nephrol Dial Transplant. 2020;35(5):737-41.doi: 10.1093/ndt/gfaa069.

16. Meijers B, Messa P, Ronco C. Safeguarding themaintenance hemodialysis patient population duringthe coronavirus disease 19 pandemic. Blood Purif.2020;49(3):259-64. doi: 10.1159/000507537.

17. Park HC, Kim DH, Yoo KD, Kim YG, Lee SH, YoonHE, et al.; Korean Society of Nephrology COVID-19Task Force Team. Korean clinical practice guidelinesfor preventing transmission of coronavirus disease2019 (COVID-19) in hemodialysis facilities. KidneyRes Clin Pract. 2020;39(2):145-50. doi: 10.23876/j.krcp.20.046.

18. Li J, Li SX, Zhao LF, Kong DL, Guo ZY. Managementrecommendations for patients with chronic kidneydisease during the novel coronavirus disease 2019(COVID-19) epidemic. Chronic Dis Transl Med.2020;6(2):119-23. doi: 10.1016/j.cdtm.2020.05.001.

19. Taj M, Kurmanaev A. El virus exhibe las debilidadesde la historia de éxito de Perú. The New York Times,16 jun. 2020. Disponible en: (consulta:13/06/2020).

20. Sakurai A, Sasaki T, Kato S, Hayashi M, Tsuzuki SI,Ishihara T, et al. Natural history of asymptomatic SARSCoV-2 infection. N Engl J Med. 2020;383(9):885-6.doi: 10.1056/NEJMc2013020.

21. Wu J, Li J, Zhu G, Zhang Y, Bi Z, Yu Y, et al. Clinicalfeatures of maintenance hemodialysis patients with2019 novel coronavirus-infected pneumonia in Wuhan,China. Clin J Am Soc Nephrol. 2020;15(8):1139-45.doi: 10.2215/CJN.04160320.

22. Valeri AM, Robbins-Juarez SY, Stevens JS, Ahn W,Rao MK, Radhakrishnan J, et al. Presentation andoutcomes of patients with ESKD and COVID-19. JAm Soc Nephrol. 2020;31(7):1409-15. doi: 10.1681/ASN.2020040470.

23. Jung HY, Lim JH, Kang SH, Kim SG, Lee YH,Lee J, et al. Outcomes of COVID-19 among patientson in-center hemodialysis: an experience from theepicenter in South Korea. J Clin Med. 2020;9(6):1688.doi: 10.3390/jcm9061688.